{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:27:10Z","timestamp":1783034830414,"version":"3.54.6"},"reference-count":18,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Child Neurol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p>\n                    The aim of this study is to investigate the homocysteine, folic acid, and vitamin B\n                    <jats:sub>12<\/jats:sub>\n                    levels in epileptic children receiving antiepileptic drugs. A total of 25 children with idiopathic epilepsy (8 valproate, 11 carbamazepine, and 6 oxcarbazepine) and 10 healthy children were included in the study. The mean homocysteine, folic acid, and vitamin B\n                    <jats:sub>12<\/jats:sub>\n                    levels in the study group were 7.57 \u00b1 3.78 \u00b5mol\/L (normal = 5-15 \u00b5mol\/L), 10.19 \u00b1 4.05 ng\/mL (normal = 3.0-17 ng\/mL), and 428.20 \u00b1 256.12 pg\/mL (normal = 193-983 pg\/mL), respectively. The differences between the mean plasma homocysteine, folic acid, and vitamin B\n                    <jats:sub>12<\/jats:sub>\n                    levels of the study and control groups were not significant ( P = .522; P = .855; P = .798, respectively). However, plasma homocysteine levels were higher than the normal cutoff point accepted for childhood in 4 (16%) of the study patients. Out of these 4 children, 3 were from the carbamazepine group and 1 was from the valproate group. Although the number of the study patients is limited, the authors recommend assessment of plasma homocysteine, serum vitamin B\n                    <jats:sub>12<\/jats:sub>\n                    , and folic acid levels in children receiving enzyme-inducing antiepileptic drugs.\n                  <\/jats:p>","DOI":"10.1177\/0883073807307081","type":"journal-article","created":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T17:59:02Z","timestamp":1199383142000},"page":"1389-1392","source":"Crossref","is-referenced-by-count":28,"title":["Homocysteine Levels in Epileptic Children Receiving Antiepileptic Drugs"],"prefix":"10.1177","volume":"22","author":[{"given":"Semra","family":"Kurul","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Division of Pediatric Neurology, Department of Pediatrics, Dokuz Eyl\u00fcl University, Izmir, Turkey,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aycan","family":"\u00dcnalp","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Pediatric Neurology, Department of Pediatrics, Dokuz Eyl\u00fcl University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulu\u00e7","family":"Yi\u015f","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Pediatric Neurology, Department of Pediatrics, Dokuz Eyl\u00fcl University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2007,12,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.CRJ05003X"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18457"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1080\/003655100448473"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.16.2070"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.10.1422"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00150-9"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00264.x"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/43.4.690"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.13.1189"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(02)00163-8"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00101-7"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(99)90204-4"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00716.x"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90087-1"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2005.05.013"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502023320502"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2005.03.005"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510220049033"}],"container-title":["Journal of Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0883073807307081","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0883073807307081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:33:33Z","timestamp":1777494813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0883073807307081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1177\/0883073807307081"],"URL":"https:\/\/doi.org\/10.1177\/0883073807307081","relation":{},"ISSN":["0883-0738","1708-8283"],"issn-type":[{"value":"0883-0738","type":"print"},{"value":"1708-8283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}